The safety and result of intratumoral steroid injection for aggressive fibromatosis

Phase 1

Recruiting

• Conditions: 1. Procedure complications2. Complications due to the steroid use; subjective interview 3. Complications due to the steroid use; laboratory investigation 4. Pain score5. Functional outcome6.; fibromatosis; intralesion; injections

• Registration Number: TCTR20150409001
• Lead Sponsor: Faculty of medicine, Chiang mai University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04-09
• Study Completion: 2015-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

1.Patients who have been diagnosed AF by MSK-Oncology Board (MSK-OB) of Chiang Mai University and give consent to participate in this research, and
2.The disease has recurred at least one episode and progressed after the wide resection had been performed, and
-Patients have experience of constant pain and not response to conservative treatment, or
-The primary lesion shows locally aggressive by involving large area of normal tissue (comparing to previous MRI), and the operation is expected to create unacceptable morbidity.

Exclusion Criteria

1.Patients who have bleeding tendency
2.Patients who depended on systemic steroid use by other conditions
3.Patients who have contra-indication for steroid use including poor control diabetes, active infection, pregnancy and lactation.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety for intratumoral steroid injection 6 months local of intratumoral injection and systemic and local steroid complications

Secondary Outcome Measures

Name	Time	Method
outcome of treatment 6 months pain score, functional score and tumor volume